HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer
Treatments for advanced prostate cancer (CaP) typically involve androgen deprivation therapy. However, most patients eventually develop castration-resistant CaP (CRPC) for which highly effective therapies are limited. We explored the efficacy of a novel agent, HE3235, in inhibiting growth of CRPC in...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , , , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Elsevier
2009-11-01
|
| মালা: | Neoplasia: An International Journal for Oncology Research |
| অনলাইন ব্যবহার করুন: | http://www.sciencedirect.com/science/article/pii/S1476558609800791 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|